Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives.
about
Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Spotlight on crizotinib in the ...... ts selection and perspectives.
@en
Spotlight on crizotinib in the ...... ts selection and perspectives.
@nl
type
label
Spotlight on crizotinib in the ...... ts selection and perspectives.
@en
Spotlight on crizotinib in the ...... ts selection and perspectives.
@nl
prefLabel
Spotlight on crizotinib in the ...... ts selection and perspectives.
@en
Spotlight on crizotinib in the ...... ts selection and perspectives.
@nl
P2093
P2860
P356
P1476
Spotlight on crizotinib in the ...... nts selection and perspectives
@en
P2093
Etienne Giroux-Leprieur
Jacques Cadranel
Vincent Fallet
P2860
P356
10.2147/LCTT.S99303
P50
P577
2016-06-17T00:00:00Z